Liberation therapy

OTHER3 trials

Sponsors

Genesis Limited, Novo Cellular Medicine Institute LLP

Conditions

Multiple Sclerosis, Relapsing-Remitting

Phase 1

A Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS

TerminatedNCT02418325

Genesis LimitedMultiple Sclerosis, Relapsing-Remitting

Start: 2015-02-28End: 2017-02-28Target: 69Updated: 2015-11-04

A Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS

Novo Cellular Medicine Institute LLPMultiple Sclerosis, Relapsing-Remitting

Start: 2015-02-28End: 2017-02-28Target: 69Updated: 2015-10-28

A Study of Autologous Bone Marrow-Derived Mononuclear Stem Cells (BM-MNC) and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS

Novo Cellular Medicine Institute LLPMultiple Sclerosis, Relapsing-Remitting

Start: 2015-02-28End: 2017-02-28Target: 69Updated: 2015-10-28